Prescription Drug Transparency and Affordability Act

Committees

• PrimaryWays and Means Committee
• AlsoEducation and Workforce Committee
• AlsoEnergy and Commerce Committee

Action history

1. March 27, 2025Introduced in House
2. March 27, 2025Introduced in House
3. March 27, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
4. March 27, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
5. March 27, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Cosponsors (2)

• Rep. Carter, Earl L. "Buddy" [R-GA-1]GA-01
• Rep. James, John [R-MI-10]MI-10

Text versions

• Introduced in House
  March 27, 2025
  HTML ↗︎PDF ↗︎XML ↗︎

Related bills

• H.R. 6703related
  Lower Health Care Premiums for All Americans Act
• H.R. 7148related
  Consolidated Appropriations Act, 2026
• S. 891related
  Bipartisan Health Care Act
• H.R. 1768related
  Lower Costs for Everyday Americans Act